Back
Brookfield Renewable Vs. Ultragenyx Pharmaceutical Industry Stock Comparison
Sell
26
BEPC.TO
Brookfield Renewable
Last Price:
40.08
Seasonality Move:
-2.5%
Sell
35
RARE
Ultragenyx Pharmaceutical
Last Price:
38.01
Seasonality Move:
3.65%
Sell
26
Brookfield Renewable (BEPC.TO)
is a Sell
Is Brookfield Renewable a Buy, Sell or Hold?
- The current Brookfield Renewable [BEPC.TO] share price is $40.81. The Score for BEPC.TO is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
- BEPC.TO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
35
Ultragenyx Pharmaceutical (RARE)
is a Sell
Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?
- The current Ultragenyx Pharmaceutical [RARE] share price is $37.42. The Score for RARE is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
- RARE is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
BEPC.TO Stock Price Chart
What is Brookfield Renewable's stock price today?
-
The Brookfield Renewable share price today is $40.81
The current trend is moderately bearish and BEPC.TO is experiencing slight selling pressure.
RARE Stock Price Chart
What is Ultragenyx Pharmaceutical's stock price today?
-
The Ultragenyx Pharmaceutical share price today is $37.42
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing selling pressure, which indicates risk of future bearish movement.
BEPC.TO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.28 | Buy |
Relative Strength Index (14 RSI): | 46.71 | Sell |
Chaikin Money Flow: | -33417 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (41.6 - 43.78) | Sell |
Bollinger Bands (100): | (31.67 - 40.87) | Buy |
RARE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.58 | Sell |
Relative Strength Index (14 RSI): | 37.74 | Sell |
Chaikin Money Flow: | -836354 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (39.26 - 42.36) | Sell |
Bollinger Bands (100): | (41.26 - 48.86) | Sell |
BEPC.TO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 41.73 | Sell |
20-day SMA: | 42.59 | Sell |
50-day SMA: | 38.81 | Buy |
200-day SMA: | 36.04 | Buy |
8-day EMA: | 41.43 | Sell |
20-day EMA: | 41.75 | Sell |
50-day EMA: | 39.84 | Buy |
200-day EMA: | 37.74 | Buy |
RARE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 41.11 | Sell |
20-day SMA: | 40.61 | Sell |
50-day SMA: | 42.43 | Sell |
200-day SMA: | 42.45 | Sell |
8-day EMA: | 40.32 | Sell |
20-day EMA: | 40.92 | Sell |
50-day EMA: | 42.29 | Sell |
200-day EMA: | 43.55 | Sell |
Brookfield Renewable Earnings Growth & BEPC.TO Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.22 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.29 per share, and an increase next year of $0.02 per share.
Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.49 per share, an increase next quarter of $0.01 per share, an increase this year of $0.90 per share, and an increase next year of $1.07 per share.
Brookfield Renewable Technical Analysis
Jun 6 | Jun 7 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 19 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
06 | 07 | 10 | 11 | 12 | 13 | 14 | 17 | 18 | 19 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Ultragenyx Pharmaceutical Technical Analysis
Jun 5 | Jun 6 | Jun 7 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
05 | 06 | 07 | 10 | 11 | 12 | 13 | 14 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |